Literature DB >> 423483

Influence of spironolactone on serum corticosteroids in primary hyperaldosteronism.

U Abshagen, S Spörl, W Oelkers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 423483     DOI: 10.1007/bf01477405

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  23 in total

1.  The effect of angiotensin II infusion on plasma corticosteroid concentrations in normal man.

Authors:  P A Mason; R Fraser; J J Morton; P F Semple; A Wilson
Journal:  J Steroid Biochem       Date:  1976-10       Impact factor: 4.292

2.  Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication.

Authors:  H Vetter; W Vetter
Journal:  Klin Wochenschr       Date:  1975-04-15

3.  Effect of a spirolactone on plasma and urinary aldosterone in primary aldosteronism.

Authors:  H Vetter; M Appenheimer; R Lucas; H Weiand; M L Herschbach; K Glänzer; F Witassek; F Krück
Journal:  Horm Res       Date:  1977

4.  Spironolactone-induced inhibition of aldosterone biosynthesis in primary aldosteronism: morphological and functional studies.

Authors:  J W Conn; D L Hinerman
Journal:  Metabolism       Date:  1977-12       Impact factor: 8.694

5.  Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case.

Authors:  J A Sundsfjord; P Marton; H Jorgensen; A Aakvaag
Journal:  J Clin Endocrinol Metab       Date:  1974-10       Impact factor: 5.958

6.  Effects of progesterone and four synthetic progestagens on sodium balance and the renin-aldosterone system in man.

Authors:  W Oelkers; M Schöneshöfer; A Blümel
Journal:  J Clin Endocrinol Metab       Date:  1974-11       Impact factor: 5.958

7.  Antihypertensive effect of spironolactone in essential, renal and mineralocorticoid hypertension.

Authors:  F Mantero; D Armanini; S Urbani
Journal:  Clin Sci Mol Med Suppl       Date:  1973-08

8.  Radioimmunoassay of free aldosterone and of its 18-oxo-glucuronide in human urine.

Authors:  P Vecsei; B Penke; A Joumaah
Journal:  Experientia       Date:  1972-05-15

9.  Interference of spironolactone therapy with adrenal steroid metabolism in secondary hyperaldosteronism.

Authors:  U Abshagen; S Spörl; M Schöneshöfer; M L'age; W Oelkers
Journal:  Klin Wochenschr       Date:  1978-04-01

10.  Effect of aldosterone antagonist canrenone on plasma aldosterone concentration and plasma renin activity, and on the excretion of aldosterone and electrolytes by man.

Authors:  H C Erbler; H Wernze; M Hilfenhaus
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.